← Open Payments lookup

JENNIFER NERF: Open Payments

NPI 1790020741 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,782 in 60 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $1,052 · 2025 $1,782

Food & beverage: $1,782
CompanyPaymentsAmount
Madrigal Pharmaceuticals15$504
Ipsen Biopharmaceuticals, Inc12$327
Gilead Sciences, Inc.13$255
Mirum Pharmaceuticals, Inc.3$138
Janssen Biotech, Inc.1$129
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$120
Mallinckrodt Hospital Products Inc.4$113
Janssen Scientific Affairs, LLC1$65
Novo Nordisk Inc2$61
Intercept Pharmaceuticals, Inc.2$45

Products named: REZDIFFRA, IQIRVO, TREMFYA, Livmarli, XIFAXAN, TERLIVAZ, Wegovy, OCALIVA.

Industry payments across MD — which companies pay providers there.